T5008 - IBD-CHEK®
A qualitative ELISA for the detection of fecal lactoferrin.
The IBD-CHEK® is an ELISA for the qualitative detection of elevated levels of lactoferrin, a marker for fecal leukocytes and an indicator of intestinal inflammation. The test can be used as an in vitro diagnostic aid to identify patients with active inflammatory bowel disease (IBD) and rule out those with active irritable bowel syndrome (IBS), which is noninflammatory. IBD, which is a condition of chronic inflammation, consists of ulcerative colitis and Crohn's disease. Both of these diseases result in elevated fecal lactoferrin. As a result, patients with these diseases test positive in the IBD-CHEK® test. In patients with active IBS, the intestine appears normal upon endoscopic examination and there is no indication of inflammation. As a result, IBS patients test negative in the IBD-CHEK® test. The IBD-CHEK® test is a simple-to-use microwell format that has a turnaround time of an hour and fifteen minutes.
Features
- Rapid screen to determine presence of intestinal inflammation
- Highly standardized
- Results within 75 minutes
Further Information
Package Insert Issued 4/08
CPT Codes Issued 3/08
Material Safety Data Sheet Issued 6/07
Poster Presentation
Clinical Evaluation of the IBD-CHEK® Test for Detecting Elevated Fecal Lactoferrin as an Indicator of Intestinal Inflammation in Pediatric Patients.
Digestive Disease Week, May 2003, Orlando Florida.